Assembly Biosciences, Inc. - Common Stock (NQ:ASMB)

20.53 +0.19 (+0.93%)

Delayed Quote Updated: 4:00 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Assembly Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead ↗

June 08, 2026

Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming...

Via MarketBeat

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands ↗

June 05, 2026

Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex virus programs while advancing ABI-6250 into multiple liver disease...

Via MarketBeat

Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference ↗

May 14, 2026

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company’s virology strategy and upcoming clinical priorities during a Bank of America-hosted discussion, emphasizing...

Via MarketBeat

Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs ↗

December 22, 2025

Via Stocktwits

Assembly Biosciences Inc (NASDAQ:ASMB) Fits the Minervini Trend Template with Strong Growth Fundamentals ↗

December 15, 2025

Assembly Biosciences (ASMB) exemplifies a high-growth momentum stock, meeting strict technical uptrend criteria and showing accelerating earnings and sales fundamentals.

Via Chartmill

Assembly Biosciences Inc (NASDAQ:ASMB) Fits the Minervini Trend Template with High Growth Momentum ↗

November 24, 2025

Assembly Biosciences (ASMB) stock meets Mark Minervini's Trend Template with a perfect technical rating, 397% from lows, and accelerating 298% revenue growth.

Via Chartmill

Forecasting The Future: 4 Analyst Projections For Assembly Biosciences ↗

October 14, 2025

Via Benzinga

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals ↗

September 29, 2025

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 16, 2025

Via Benzinga

This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

March 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 16, 2024

Via Benzinga

Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants ↗

September 23, 2024

Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent genital herpes. The drug showed a favorable safety profile and achieved...

Via Benzinga

ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024 ↗

August 09, 2024

ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Insiders Buying American Software And 2 Other Stocks ↗

July 09, 2024

Via Benzinga

ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024 ↗

May 13, 2024

ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023 ↗

March 28, 2024

ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023 ↗

March 25, 2024

ASMB stock results show that Assembly Biosciences missed analyst estimates for earnings per share the second quarter of 2023.

Via InvestorPlace

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 18, 2023

Via Benzinga

Crude Oil Moves Lower; Bank of America Profit Beats Expectations ↗

October 17, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to...

Via Benzinga

Topics Stocks

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings ↗

October 17, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52....

Via Benzinga

Topics Stocks

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.